The SITC 2017 Microlearning: Acquired Resistance Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.
The Acquired Resistance Series contains three modules.
Module 1: Acquired Resistance Checkpoint Inhibitors in Lung Cancer
Katerina Politi, PhD - Yale School of Medicine
Module 2: Acquired Resistance to PD-1 Blockade in Melanoma
Antoni Ribas, MD, PhD - University of California, Los Angeles
Module 3: Acquired Resistance in Melanoma
Annette Paschen, MD - University Hospital Essen
These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.
Course Available Beginning: August 16, 2018
Upon completion of this activity, participants will be able to:
- Describe commonly targeted mechanisms that can result in acquired resistance to immunotherapy.
- Provide specific examples of acquired resistance to immunotherapy.
- Characterize differences in acquired resistance between diseases.